Analysts: Valeant Pharmaceuticals International Inc (VRX.N)

VRX.N on New York Stock Exchange

123.52USD
25 Jul 2014
Price Change (% chg)

$-0.84 (-0.68%)
Prev Close
$124.36
Open
$123.91
Day's High
$124.16
Day's Low
$122.61
Volume
134,555
Avg. Vol
409,853
52-wk High
$152.92
52-wk Low
$90.93

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 2.34 December 28 Jul 2014

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 9 9 9 9
(2) OUTPERFORM 5 6 7 6
(3) HOLD 2 1 1 1
(4) UNDERPERFORM 1 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.71 1.50 1.53 1.50

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-14 16 2,144.71 2,318.00 1,983.00 2,279.50
Quarter Ending Dec-14 16 2,299.51 2,523.00 2,179.77 2,331.00
Year Ending Dec-14 18 8,382.48 8,665.20 8,090.00 8,138.68
Year Ending Dec-15 18 9,005.27 9,792.00 8,364.11 8,843.99
Earnings (per share)
Quarter Ending Sep-14 16 2.34 2.49 2.15 2.49
Quarter Ending Dec-14 16 2.69 2.84 2.57 2.57
Year Ending Dec-14 17 8.69 8.91 8.45 8.37
Year Ending Dec-15 17 10.44 11.62 9.26 10.10

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-14 1,968.73 1,886.20 82.53 4.19
Quarter Ending Dec-13 2,058.94 2,063.76 4.82 0.23
Quarter Ending Sep-13 1,671.61 1,541.73 129.88 7.77
Quarter Ending Jun-13 1,114.31 1,095.76 18.55 1.66
Quarter Ending Mar-13 1,090.44 1,068.35 22.09 2.03
Earnings (per share)
Quarter Ending Mar-14 1.72 1.76 0.04 2.12
Quarter Ending Dec-13 2.06 2.15 0.09 4.40
Quarter Ending Sep-13 1.41 1.43 0.02 1.17
Quarter Ending Jun-13 1.28 1.34 0.06 4.64
Quarter Ending Mar-13 1.25 1.30 0.05 4.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-14 2,144.71 2,148.61 2,155.82 2,171.94 2,279.50
Quarter Ending Dec-14 2,299.51 2,302.58 2,308.62 2,309.87 2,331.00
Year Ending Dec-14 8,382.48 8,397.48 8,410.33 8,430.94 8,138.68
Year Ending Dec-15 9,005.27 9,030.95 9,054.53 9,099.37 8,843.99
Earnings (per share)
Quarter Ending Sep-14 2.34 2.35 2.36 2.38 2.49
Quarter Ending Dec-14 2.69 2.69 2.70 2.71 2.57
Year Ending Dec-14 8.69 8.71 8.73 8.76 8.37
Year Ending Dec-15 10.44 10.50 10.53 10.58 10.10

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-14 0 0 0 2
Quarter Ending Dec-14 0 0 1 1
Year Ending Dec-14 0 0 1 1
Year Ending Dec-15 0 0 0 2
Earnings
Quarter Ending Sep-14 0 0 0 1
Quarter Ending Dec-14 0 0 0 1
Year Ending Dec-14 0 0 0 1
Year Ending Dec-15 0 0 0 1

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Stock Traders Daily
$20.00
Provider: Pechala's Reports
$25.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks